WHO ICTRP trial
Pilot study of association of VEGF polymorphisms with clinical efficacy and…
EUCTR2007-004487-53-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2007-004487-53-IT |
|---|---|
| Public title | Pilot study of association of VEGF polymorphisms with clinical efficacy and tolerability of therapy in patients affected by exudative (neovascular) age-related macular degeneration. - DEGENE |
| Scientific title | Pilot study of association of VEGF polymorphisms with clinical efficacy and tolerability of therapy in patients affected by exudative (neovascular) age-related macular degeneration. - DEGENE |
| Primary sponsor | AZIENDA OSPEDALIERA PISANA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Exudative and atrophic age-related macular degeneration. MedDRA version: 6.1 Level: PT Classification code 10025409 |
| Interventions | Trade Name: MACUGEN*INIET 1 SIR 0,3MG Pharmaceutical Form: Solution for injection INN or Proposed INN: PEGAPTANIB SODICO Concentration unit: µg microgram(s) Concentration type: equal Concentration number: 300- Trade Name: LUCENTIS*INIET 1FL… |
| Registration date | Dec 10, 2007 |
| Secondary IDs | 2312/2007 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: